Juan Luis Callejas‐Valera

University of Castilla-La Mancha — Spain

Medicine · Health Sciences

15h-index1.1kcitations27works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(5), Immunotherapy and Immune Responses(4), Cancer-related Molecular Pathways(4), Virus-based gene therapy research(4), RNA Interference and Gene Delivery(3)

Publications27 total

Retraction Note: P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance
Oncogene·2024· 1 citedOpen Access
Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
Cancers·2022· 4 citedOpen Access
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
Oncogene·2020· 94 citedOpen Access
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
Journal of Clinical Oncology·2020· 117 citedOpen Access
Sema3F Suppresses Tumor Initiation Through Alteration of the Immunological Tumor Microenvironment
The FASEB Journal·2020
Abstract B51: Novel syngeneic animal model of tobacco-associated oral cancer reveals the activity of in situ anti-CTLA-4
Cancer Immunology Research·2020
A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis
International Journal of Experimental Pathology·2020· 18 citedOpen Access
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
Nature Communications·2019· 166 citedOpen Access
Novel syngeneic animal model of tobacco-associated oral cancer reveals the activity of <i>in situ</i> anti-CTLA-4
2019Open Access
β2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
Oncogenesis·2018· 25 citedOpen Access
Transcriptional signature primes human oral mucosa for rapid wound healing
Science Translational Medicine·2018· 271 cited
1395 Unique transcriptional signature primes oral mucosa for rapid wound healing in humans
Journal of Investigative Dermatology·2018· 4 citedOpen Access
Abstract 4800: A next-gen animal model to Study PIK3CA<i>-</i>mTOR driven HPV-related oral malignancies
Cancer Research·2017
E1a is an exogenous in vivo tumour suppressor
Cancer Letters·2017· 9 cited
Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes
PLoS ONE·2017· 10 citedOpen Access
mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model
Carcinogenesis·2016· 39 citedOpen Access
MKP1: Jekyll and Hyde for E1A
Aging·2016· 1 citedOpen Access
A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in <i>PIK3CA</i>+ oral cancers
Oncotarget·2016· 25 citedOpen Access
MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells
Oncotarget·2015· 12 citedOpen Access
E1a promotes c-Myc-dependent replicative stress
Cell Cycle·2013· 13 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

J. Silvio Gutkind(15), Ricardo Sánchez‐Prieto(11), Alfredo Molinolo(10), Miguel Ángel de la Cruz-Morcillo(8), Ramiro Iglesias‐Bartolomé(6), Panomwat Amornphimoltham(6), Pedro Melgar–Rojas(6), Eva María Galán‐Moya(6), Zhiyong Wang(5), Daniel Martı́n(5), Ezra E.W. Cohen(5), Elena García García(5), Jesús García‐Cano(5), Francisco J. Cimas(5), Colleen L. Doçi(4), Michael M. Allevato(4), Mara Gilardi(4), María Llanos Valero(4), Laura Arias‐González(4), Joseph A. Califano(4)